Centene (NYSE: CNC) Surges 14% on Q1 Strength and Medicaid Momentum
Centene stock jumps 13.95% following Q1 results driven by strong revenue growth and positive Medicaid trends.
Centene Corporation (NYSE: CNC) is a healthcare company, listed on the NYSE. Alpha Stocks Insight has published 2 articles on CNC since April 28, 2026, most recently "Centene (NYSE: CNC) Names Chris Neczypor as Next CFO in Planned Leadership Transition" on Tuesday, August 18, 2026. Coverage to date spans Health Care and Earnings Report, tracking CNC's earnings, analyst activity, and material corporate events. New coverage is added each trading day.
Drew Asher steps down December 31, 2026 after guiding Centene from $126B to $195B in revenue. His successor joins from Lincoln Financial in September.
Centene stock jumps 13.95% following Q1 results driven by strong revenue growth and positive Medicaid trends.
Important Legal Disclaimer
This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.
Affiliate disclosure: This site may contain affiliate links to brokerage platforms. If you open an account through one of our links, we may earn a commission at no additional cost to you. Affiliate relationships do not influence our editorial content or stock coverage decisions.
Important Legal Disclaimer: This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.